跳至主要内容
临床试验/CTRI/2010/091/000094
CTRI/2010/091/000094尚未招募1 期

Is the use of bone marrow derived mononuclear cells safe and feasible in prevention of wound breakdown in patients undergoing abdominoperineal excision after neoadjuvant Chemoradiotherapy for Carcinoma Rectum ? a Pilot study

CMCH, Vellore0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients diagnosed with carcinoma rectum undergoing Abdominoperineal excision following Long Course Chemoradiotherapy in Surgery Unit 5, using Conventional RT at 50.4 Gy over 28 fractions.

排除标准

  • 1.Gross contamination intra op from Rectum or Urethra
  • 2.Known immunosuppression
  • 3. Patients who were diagnosed with hematological disease.
  • 4. Patients receiving conformal radiotherapy

研究者

发起方
CMCH, Vellore

相似试验